SEKISUI Diagnostics
Alan Bauer has extensive work experience in the finance and accounting sector. Alan has held various senior roles at Bristol-Myers Squibb Company and its subsidiaries, including Vice President - Global Finance at Sekisui Diagnostics, LLC. Alan has also worked as a Director, Pricing & Reimbursement and Director, Order-To-Cash & Distribution Management. Alan has a strong background in business development, project management, and manufacturing productivity. Alan started their career at Bristol-Myers Squibb in 1987 and has since progressed through multiple positions, including Controller, Director of Accounting, and Senior Manager - Financial Planning & Analysis.
Alan Bauer attended Washington and Lee University, where they obtained a Bachelor of Science degree in Accounting. Alan later enrolled at Fairleigh Dickinson University-Florham Campus and pursued an MBA with a focus on Finance.
SEKISUI Diagnostics
4 followers
Headquartered in Burlington, MA, for 40 years SEKISUI Diagnostics has been committed to helping improve the lives of patients by providing innovative medical diagnostics to physicians and laboratories. We continue to invest in the areas of diabetes, infectious disease, coagulation, diagnostic enzymes and automated systems, and have a leading position as a provider of rapid tests in the US and high throughput coagulation systems in Japan. Our workforce spans six sites located in four countries. We are a sister company to SEKISUI Medical in Japan, making us a worldwide company with R&D and Manufacturing facilities on three continents. We develop, manufacture, and supply billions of tests each year to the global healthcare market through our commercial networks and partners. Our product lines include: • Clinical chemistry reagents • Coagulation reagents • Point-of-care rapid tests and immunoassay system • Enzymes and specialty biochemicals